MED28在口腔鳞状细胞癌及癌旁组织中的表达及临床特征分析

项钊; 吕俊; 蔡俊; 王亚丽; 张纲; 谭颖徽

doi:10.16016/j.1000-5404.202101098

您当前的位置：

首页 >

文章列表页 >

MED28在口腔鳞状细胞癌及癌旁组织中的表达及临床特征分析

临床医学 | 更新时间：2026-01-09

- MED28在口腔鳞状细胞癌及癌旁组织中的表达及临床特征分析
- Expression of MED28 in oral squamous cell carcinoma and para-carcinoma tissues and its correlation with clinical characteristics
- 第三军医大学学报 2021年43卷第8期页码：755-760
- 作者机构：
  
  400037 重庆，陆军军医大学(第三军医大学)第二附属医院口腔颌面外科
- 作者简介：
  
  [谭颖徽，E-mail: tanyhxqkq@163.com TAN Yinghui, E-mail: tanyhxqkq@163.com
- 基金信息：
  
  陆军军医大学（第三军医大学）人才扶持计划(2019);陆军军医大学第二附属医院临床重大创新特色技术项目(2018JSLC0022)
- DOI：10.16016/j.1000-5404.202101098
  中图分类号： R341;R730.23;R739.85
- 收稿：2021-01-11，
  
  修回：2021-02-01，
  
  纸质出版：2021-04-30
- 稿件说明：
移动端阅览
项钊, 吕俊, 蔡俊, 等. MED28在口腔鳞状细胞癌及癌旁组织中的表达及临床特征分析[J]. 第三军医大学学报, 2021,43(8):755-760.

Zhao XIANG, Jun LYU, Jun CAI, et al. Expression of MED28 in oral squamous cell carcinoma and para-carcinoma tissues and its correlation with clinical characteristics[J]. Journal of Third Military Medical University, 2021, 43(8): 755-760.
项钊, 吕俊, 蔡俊, 等. MED28在口腔鳞状细胞癌及癌旁组织中的表达及临床特征分析[J]. 第三军医大学学报, 2021,43(8):755-760. DOI： 10.16016/j.1000-5404.202101098.

Zhao XIANG, Jun LYU, Jun CAI, et al. Expression of MED28 in oral squamous cell carcinoma and para-carcinoma tissues and its correlation with clinical characteristics[J]. Journal of Third Military Medical University, 2021, 43(8): 755-760. DOI： 10.16016/j.1000-5404.202101098.

摘要

目的

探讨中介体复合物亚基28蛋白(mediator complex subunit 28 protein

MED28)于口腔鳞状细胞癌(oral squamous cell carcinoma

OSCC)、癌旁组织中表达及其与病理特征、预后的关系。

方法

选取2015年1月至2020年6月首次在我院口腔颌面外科住院手术的OSCC患者标本142例，其中91份OSCC标本包含癌旁正常组织。免疫组织化学法于OSCC及癌旁组织石蜡切片检测MED28的表达。分析OSCC组织与癌旁组织的MED28表达差异。计算MED28表达结果即切片最终评分的平均值，并以此为标准将OSCC患者分为MED28低表达组和MED28高表达组，用Logistic回归模型分析MED28表达与病理特征的关系，Kaplan-Meier法分析MED28的表达与预后的关系，并用COX回归模型分析预后的影响因素。

结果

与癌旁组织比较，MED28在OSCC组织中高表达(

0.01)。Logistic回归模型分析显示MED28表达与吸烟、淋巴结转移相关(

0.05)，Kaplan-Meier生存分析显示MED28低表达组总体生存时间(overall survival

OS)显著高于高表达组(

0.01)。吸烟和性别也是影响预后的相关因素(

0.05)。

结论

MED28在OSCC患者癌组织中高表达，可能与OSCC的发生、发展相关，并影响预后，其表达与吸烟、淋巴结转移有关。

Abstract

Objective

To investigate the expression of mediator complex subunit 28 protein (MED28) in oral squamous cell carcinoma (OSCC) and para-carcinoma tissues

and its correlation with pathological features and prognosis.

Methods

A total of 142 OSCC specimens were collected from the inpatients undergoing surgical treatment in our department from January 2015 to June 2020. Among these specimens

91 had para-carcinoma tissues. Immunohistochemistry was used to detect the MED28 expression in OSCC and para-carcinoma paraffin sections.

Chi

-square test was used to analyze the difference of MED28 expression between OSCC and para-carcinoma tissues. The patients were then divided into MED28-high and MED28-low expression groups according to its median expression level. Logistic regression model was used to analyze the relationship between MED28 expression and pathological features

Kaplan-Meier survival analysis was selected to study the relationship between the expression and prognosis

and COX regression analysis was employed to analyze the prognostic factors.

Results

MED28 was significantly highly expressed in the OSCC tissues than para-carcinoma tissues (

0.01). Logistic regression model showed that MED28 expression is related with smoking and lymph node metastasis(

0.05). Kaplan-Meier survival analysis indicated that overall survival (OS) in the patients was significantly higher in the MED28-low expression group than the MED28-high expression group (

0.01). Gender and smoking status were identified as related factors influencing prognosis (

0.05).

Conclusion

MED28 is highly expressed in the OSCC tissues

which might be related to the occurrence and development of OSCC. It also affects the prognosis

and is related to smoking status and lymph node metastasis.

关键词

Keywords

references

ALLEN B L, TAATJES D J. The mediator complex: a central integrator of transcription[J]. Nat Rev Mol Cell Biol, 2015, 16(3): 155-166. DOI: 10.1038/nrm3951.

ROBINSON P J, TRNKA M J, BUSHNELL D A, et al . Structure of a complete mediator-RNA polymerase Ⅱ pre-initiation complex[J ] . Cell, 2016, 166(6): 1411-1422. e16. DOI: 10.1016/j.cell.2016.08.050.

CLARK A D, OLDENBROEK M, BOYER T G. Mediator kinase module and human tumorigenesis[J]. Crit Rev Biochem Mol Biol, 2015, 50(5): 393-426. DOI: 10.3109/10409238. 2015.1064854.

SCHIANO C, CASAMASSIMI A, RIENZO M, et al . Involvement of Mediator complex in malignancy[J ] . Biochim Biophys Acta, 2014, 1845(1): 66-83. DOI: 10.1016/j.bbcan.2013.12.001.

SHAIKHIBRAHIM Z, OFFERMANN A, HALBACH R, et al . Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma[J ] . Am J Pathol, 2015, 185(4): 1114-1122. DOI: 10.1016/j.ajpath.2014.12.010.

SCHMITZ S, MACHIELS J P. Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications[J]. Expert Rev Anticancer Ther, 2010, 10(9): 1471-1484. DOI: 10.1586/era.10.115.

PURAM S V, TIROSH I, PARIKH A S, et al . Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer[J ] . Cell, 2017, 171(7): 1611-1624. e24. DOI: 10.1016/j.cell.2017.10.044.

YUAN H T, YAN M, ZHANG G X, et al . CancerSEA: a cancer single-cell state atlas[J ] . Nucleic Acids Res, 2019, 47(D1): D900-D908. DOI: 10.1093/nar/gky939.

MONTOJO J, ZUBERI K, RODRIGUEZ H, et al . GeneMANIA: Fast gene network construction and function prediction for Cytoscape[J ] . F1000Res, 2014, 3: 153. DOI: 10.12688/f1000research.4572.1.

DE ANDRADE N P, RODRIGUES M F S D, RODINI C O, et al . Cancer stem cell, cytokeratins and epithelial to mesenchymal transition markers expression in oral squamous cell carcinoma derived from ortothopic xenoimplantation of CD44 high cells[J ] . Pathol-Res Pract, 2017, 213(3): 235-244. DOI: 10.1016/j.prp.2016.12.009.

LEE M, JI H, FURUTA Y, et al . p120-catenin regulates REST and CoREST, and modulates mouse embryonic stem cell differentiation[J ] . J Cell Sci, 2014, 127(pt 18): 4037-4051. DOI: 10.1242/jcs.151944.

XIANG Z, ZHOU S, LIANG S, et al . RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells[J ] . J Oral Pathol Med, 2020, 49(8): 741-750. DOI: 10.1111/jop.13022.

CHO J, CHOI J S, LEE J H, et al . MED28 over-expression shortens the cell cycle and induces genomic instability[J ] . Int J Mol Sci, 2019, 20(7): 1746. DOI: 10.3390/ijms20071746.

HUANG C Y, HSIEH N T, LI C I, et al . MED28 regulates epithelial-mesenchymal transition through NFκB in human breast cancer cells[J ] . J Cell Physiol, 2017, 232(6): 1337-1345. DOI: 10.1002/jcp.25610.

HUANG C Y, CHOU Y H, HSIEH N T, et al . MED28 re-gulates MEK1-dependent cellular migration in human breast cancer cells[J ] . J Cell Physiol, 2012, 227(12): 3820-3827. DOI: 10.1002/jcp.24093.

LEE M F, HSIEH N T, HUANG C Y, et al . All Trans-retinoic acid mediates MED28/HMG box-containing protein 1 (HBP1)/β-catenin signaling in human colorectal cancer cells[J ] . J Cell Physiol, 2016, 231(8): 1796-1803. DOI: 10.1002/jcp.25285.

HSIEH N T, HUANG C Y, LI C C, et al . MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells[J ] . J Cell Physiol, 2019, 234(7): 11265-11275. DOI: 10.1002/jcp.27784.

LI L, WALSH R M, WAGH V, et al . Mediator subunit Med28 is essential for mouse peri-implantation development and plurip otency[J ] . PLoS ONE, 2015, 10(10): e0140192. DOI: 10.1371/journal.pone.0140192.

YAO H L, GOLDMAN D C, FAN G, et al . The corepressor Rcor1 is essential for normal myeloerythroid lineage differentiation[J ] . Stem Cells, 2015, 33(11): 3304-3314. DOI: 10.1002/stem.2086.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

口腔鳞状细胞癌增殖相关基因预后评估模型的建立

基于中国人群的雌激素受体表达新分层（低/中/高）可更精准地预测HR⁺/HER2^-早期乳腺癌患者的预后

DLGAP5通过调控Warburg效应促进口腔鳞状细胞癌的进展

转录因子TGIF1高表达胃癌的免疫抑制性微环境特征及临床意义分析